Adherex Technologies Inc.: Adherex Announces ASCO Abstract of ADH-1 in Melanoma

RESEARCH TRIANGLE PARK, NORTH CAROLINA (MARKET WIRE) Adherex Technologies Inc. (AMEX: ADH)(TSX: AHX), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today the publication of an abstract on the phase I/II study of ADH-1 in combination with isolated limb... [read full story]                    

Add Comment
There are also 5 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies